evans blue has been researched along with exenatide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Gao, S; Jacobson, O; Kiesewetter, DO; Lang, L; Liu, Y; Ma, Q; Ma, Y; Wang, G; Zhang, H; Zhu, L | 1 |
| Chen, H; Chen, X; Jacobson, O; Kiesewetter, DO; Lang, L; Liu, Y; Ma, Y; Niu, G; Wang, G; Wu, H; Zhang, X; Zhu, L | 1 |
| Brooks, BR; Chen, X; Dai, Y; Fu, X; Jacobson, O; Kiesewetter, DO; Lang, L; Lau, J; Liu, G; Liu, Y; Ma, Y; Niu, G; Tian, R; Wang, Z; Yu, G; Zeng, Q; Zhu, G; Zhu, S | 1 |
3 other study(ies) available for evans blue and exenatide
| Article | Year |
|---|---|
Stable Evans Blue Derived Exendin-4 Peptide for Type 2 Diabetes Treatment.
Topics: Animals; Chromatography, High Pressure Liquid; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drug Stability; Evans Blue; Exenatide; Humans; Hypoglycemic Agents; Maleimides; Mice, Inbred C57BL; Naphthalenesulfonates; Peptides; Serum Albumin; Venoms | 2016 |
Chemical Conjugation of Evans Blue Derivative: A Strategy to Develop Long-Acting Therapeutics through Albumin Binding.
Topics: Albumins; Animals; Cell Line, Tumor; Copper Radioisotopes; Evans Blue; Exenatide; Fluorine Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Hypoglycemic Agents; Male; Mice; Mice, Inbred C57BL; Peptides; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Venoms | 2016 |
An Albumin Sandwich Enhances in Vivo Circulation and Stability of Metabolically Labile Peptides.
Topics: Animals; Binding Sites; Cell Line, Tumor; Evans Blue; Exenatide; Humans; Hypoglycemic Agents; Mice; Models, Molecular; Pharmaceutical Preparations; Protein Binding; Protein Multimerization; Proteolysis; Rats; Serum Albumin | 2019 |